← Leaderboards
Bree Beardsley Aldridge
Emory University
$9,957,366
Attributed
$14,741,927
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2013–25$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,741,927 · 4
By mechanism
R01$11,823,677 · 3
DP2$2,918,250 · 1
Top collaborators
- Jyothi Rengarajan6 shared
- Denise E Kirschner5 shared
- Veronique Dartois2 shared
Most similar at Emory University
Same institution · by research overlap
- Jyothi Rengarajan$20,334,619
- Hao Gao$3,732,648
- Russell Ryan Kempker$3,115,410
- Brendan Prideaux$2,275,840
- Kurt A Schalper$6,187,130
Others in their field
Top investigators on “Growth”
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$233,131,631
- Albert Lazzarini · California Institute Of Technology$170,110,000
- David H Reitze · University Of Florida$170,110,000
- Garret A Fitzgerald · University Of Pennsylvania$153,184,124
- David Heimbrook · Leidos Biomedical Research, Inc.$143,966,408
- Carol Nesel · Westat$116,355,411
Research focus
GrowthInfectionStressDesignPharmaceutical PreparationsMycobacterium TuberculosisTuberculosisDrug ToleranceLungLesionGranulomaResponsePredispositionCellsImmuneComputer ModelsTreatment ProtocolsMathematical ModelPathogenRegimenAntibioticsBacteriaNovel TherapeuticsTuberculosis Treatment
Grant awards (17)
Deep spatial immune profiling of granulomas and M. tuberculosis adaptation to disease and treatment$1,120,958
R01 · FY2025 · AI
Deep spatial immune profiling of granulomas and M. tuberculosis adaptation to disease and treatment$95,603
R01 · FY2025 · AI
Deep spatial immune profiling of granulomas and M. tuberculosis adaptation to disease and treatment$1,130,293
R01 · FY2024 · AI
Lesion-centric optimization of multidrug therapies for tuberculosis$818,294
R01 · FY2024 · AI · contact PI
Deep spatial immune profiling of granulomas and M. tuberculosis adaptation to disease and treatment$36,083
R01 · FY2024 · AI
Deep spatial immune profiling of granulomas and M. tuberculosis adaptation to disease and treatment$1,192,738
R01 · FY2023 · AI
Lesion-centric optimization of multidrug therapies for tuberculosis$823,212
R01 · FY2023 · AI · contact PI
Single-cell factors of tuberculosis drug tolerance during adaptation to environmental stressors$705,360
R01 · FY2023 · AI · contact PI
Deep spatial immune profiling of granulomas and M. tuberculosis adaptation to disease and treatment$1,255,581
R01 · FY2022 · AI
Lesion-centric optimization of multidrug therapies for tuberculosis$827,669
R01 · FY2022 · AI · contact PI
Single-cell factors of tuberculosis drug tolerance during adaptation to environmental stressors$708,159
R01 · FY2022 · AI · contact PI
Lesion-centric optimization of multidrug therapies for tuberculosis$832,259
R01 · FY2021 · AI · contact PI
Single-cell factors of tuberculosis drug tolerance during adaptation to environmental stressors$708,159
R01 · FY2021 · AI · contact PI
Lesion-centric optimization of multidrug therapies for tuberculosis$869,259
R01 · FY2020 · AI · contact PI
Single-cell factors of tuberculosis drug tolerance during adaptation to environmental stressors$700,050
R01 · FY2020 · AI · contact PI
Quantitative Design of Multi-drug Regiments for Tuberculosis$443,250
DP2 · FY2018 · LM · contact PI
Quantitative Design of Multi-drug Regiments for Tuberculosis$2,475,000
DP2 · FY2013 · LM · contact PI